NOTICE OF 2020 ANNUAL GENERAL MEETING
Notice is hereby given that the Annual General Meeting of Shareholders of Clarity Pharmaceuticals Ltd will be held at 10:00am on Thursday 19th of November 2020 by webcast to transact the business set out below.
The webcast will be hosted on Zoom – https://www.zoom.us/join. Meeting ID is: 998 5420 8151. Shareholders are required to register in advance to attend the meeting. To participate in the AGM you will need to register for the meeting at this link (click here to open the registration link in your web browser).
You will be prompted to create a free Zoom account if you do not already have one. Registration is open now and will close at 9:00am (Sydney time) on Thursday 19 November 2020, 1 hour before the AGM commences. Early registration is encouraged.
ORDINARY BUSINESS
Annual Accounts
“To receive and consider the Annual Company Financial Statements and reports of the Directors and the Auditor for the period ended 30 June 2020.”
The Company’s Annual Financial Statements and reports of the Directors and the Auditor for the year ended 30 June 2020 will be presented at the Annual General Meeting for consideration by Shareholders. No resolution is required in respect of these reports.
A copy of the Financial Statements has been sent to all Shareholders, however, if any Shareholder would like a further copy it can be obtained by contacting the Company Secretary Robert Vickery by email at Robert.Vickery@claritypharmaceuticals.com.
QUESTIONS AT THE MEETING
Shareholders will be given a reasonable opportunity to ask questions and to make comments on the Financial Statements and the management and performance of the Company.
The Company’s Auditor will be present at the meeting. Shareholders will be given a reasonable opportunity to ask questions of the Auditor about the conduct of the audit, the preparation and content of the Auditor’s report, the accounting policies adopted by the Company and the independence of the Auditor.
There will also be an opportunity to ask questions on matters other than the Financial Statements, either by prior submission or during the meeting following the presentations. Shareholders can submit questions by email before the meeting to lisa.sadetskaya@claritypharmaceuticals.com. Submitting in advance, where possible, is encouraged to assist with smooth running of the meeting.
We look forward to your participation at the Annual General Meeting of Shareholders.
Dated this 26th day of October 2020
BY ORDER OF THE BOARD
Alan Taylor
Executive Chairman
